Cosmetics

Search documents
5 Monster Stocks to Hold for the Next 5 Years
The Motley Fool· 2025-07-11 10:25
There are a number of companies that are well positioned to deliver solid revenue and earnings growth over the next several years.Here are five monster stocks to buy right now and hold for the next five years or more. 1. AmazonWhile Amazon (AMZN -0.13%) is a leader in e-commerce and cloud computing, what it is doing behind the scenes is the best reason to own the stock. At its cloud computing division, the company is helping customers customize, build, and deploy their own artificial intelligence (AI) model ...
全球棕榈油酸市场核心生产商排名及市场占有率
QYResearch· 2025-07-11 09:28
棕榈油酸是一种天然存在的单不饱和脂肪酸。它广泛存在于动植物脂肪中,尤其常见于海洋鱼油、乳制品和某些植物油中。棕榈油酸可在人 体内通过棕榈酸脱氢生成。它具有抗炎、促进新陈代谢和促进皮肤健康等生物学功能,常用于食品、化妆品和保健品行业。棕榈油酸,也称 为棕榈油酸酯或 (9Z)- 十六碳烯酸酯,属于长链脂肪酸有机化合物。长链脂肪酸是指带有 13 至 21 个碳原子的脂肪族链段的脂肪酸。棕榈油 酸是一种疏水性极强的分子,几乎不溶于水,且呈中性。 棕榈油酸, C16 : 1 酸,俗称 Omega-7 脂肪酸,科学界对其对许多重要健康应用的潜在益处进行了研究,包括心脏健康、抗炎、胰岛素敏 感性、补充粘膜水分以及对皮肤、头发和指甲的抗衰老功效。 据 QYResearch 调研团队最新报告"全球棕榈油酸市场报告 2025-2031 "显示,预计 2031 年全球棕榈油酸市场规模将达到 0.9 亿美元,未来几 年年复合增长率 CAGR 为 7.8% 。 棕榈油酸 ,全球市场总体规模 全球 棕榈油酸 市场前 8 强生产商排名及市场占有率(基于 2 02 5 年调研数据;目前最新数据以本公司最新调研数据为准) 根据 QYResea ...
5 Growth Stocks to Buy and Hold Forever
The Motley Fool· 2025-07-11 07:20
When it comes to consumer-facing businesses with long-term growth potential, a few companies stand out. While technology stocks get a lot of attention, and deservedly so, the consumer space is also full of solid companies with long growth trajectories.Here's a look at five consumer-focused stocks built for growth to buy and hold for the the long haul.AmazonThere is a reason why Amazon (AMZN -0.13%) has grown to become one of the world's largest companies: It isn't afraid to innovate and it invests to win. Y ...
X @Investopedia
Investopedia· 2025-07-11 00:00
Shares of Estée Lauder Cos. surged Thursday after Bank of America reinstated coverage of the stock with a "buy" rating and a bullish price target, citing optimism about the cosmetics giant's recovery efforts. https://t.co/WhFWdzgHTz ...
e.l.f. Beauty (ELF) Stock Slides as Market Rises: Facts to Know Before You Trade
ZACKS· 2025-07-10 22:46
Company Performance - e.l.f. Beauty's stock closed at $115.37, down 1.95% from the previous day, underperforming the S&P 500 which gained 0.28% [1] - The stock has decreased by 5.51% over the past month, compared to a 1.44% loss in the Consumer Staples sector and a 4.37% gain in the S&P 500 [1] Upcoming Earnings - The company is expected to report an EPS of $0.85, reflecting a 22.73% decrease from the same quarter last year [2] - Revenue is forecasted to be $350.96 million, indicating an 8.16% increase year-over-year [2] Full Year Projections - For the full year, earnings are projected at $3.66 per share and revenue at $1.65 billion, representing increases of 7.96% and 25.39% respectively from the previous year [3] - Recent changes in analyst estimates are crucial as they often indicate shifts in near-term business trends, with positive revisions suggesting confidence in performance [3] Valuation Metrics - e.l.f. Beauty has a Forward P/E ratio of 32.14, which is higher than the industry average of 21.07 [6] - The company has a PEG ratio of 2.07, compared to the industry average PEG ratio of 1.23 [6] Industry Context - The Cosmetics industry is part of the Consumer Staples sector, holding a Zacks Industry Rank of 9, placing it in the top 4% of over 250 industries [7] - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]
Why Estee Lauder Could Be Your Next 30% Gain
Benzinga· 2025-07-10 19:25
Core Viewpoint - Estee Lauder Companies Inc. is set for a significant turnaround driven by its "Beauty Reimagined" strategy, despite recent challenges, particularly in Asia, with a forecasted stock price increase of 30% [1][2]. Group 1: Financial Performance and Projections - The company is expected to achieve a 4% revenue CAGR through fiscal year 2027 and a margin expansion of 430 basis points to 12%, with EBIT projected to be 10% above consensus [3]. - Earnings per share (EPS) have dropped by 80% from their peak due to weakness in Asia, particularly in China and Hainan, but improved demand is anticipated in the upcoming quarters [5]. - The current trading multiple of 2.4x EV/sales indicates a significant discount compared to peers like L'Oréal, suggesting potential for a re-rating of the stock [7]. Group 2: Strategic Initiatives - The "Beauty Reimagined" strategy focuses on innovation speed, new channels, and cost efficiency, with a potential 10% reduction in headcount yielding up to $1 billion in savings, which may be reinvested into a 25% increase in brand and consumer marketing [4]. - The company generates $14 billion in revenue across 25 brands, positioning itself as the second-largest player in the $160 billion global prestige beauty market [4]. Group 3: Market Conditions - A more rational market environment during key shopping festivals and stabilizing trends in Hainan are expected to support growth in fiscal year 2026, while Korea's travel retail segment faces ongoing pressure [6].
Estee Lauder gains after BofA reinstates coverage with Buy rating, sees 30% upside
Proactiveinvestors NA· 2025-07-10 19:01
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Helen of Troy (HELE) Q1 Earnings and Revenues Miss Estimates
ZACKS· 2025-07-10 12:56
Company Performance - Helen of Troy (HELE) reported quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.91 per share, and down from $0.99 per share a year ago, representing an earnings surprise of -54.95% [1] - The company posted revenues of $371.66 million for the quarter ended May 2025, missing the Zacks Consensus Estimate by 6.93%, and down from $416.85 million year-over-year [2] - Over the last four quarters, Helen of Troy has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Helen of Troy shares have lost about 48.2% since the beginning of the year, while the S&P 500 has gained 6.5% [3] - The current Zacks Rank for Helen of Troy is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is $1.07 on revenues of $458.04 million, and for the current fiscal year, it is $5.04 on revenues of $1.84 billion [7] - The outlook for the cosmetics industry, where Helen of Troy operates, is currently in the top 4% of over 250 Zacks industries, suggesting a favorable environment for performance [8]
Are Investors Undervaluing Coty (COTY) Right Now?
ZACKS· 2025-07-09 14:41
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value ...
维琪科技冲击北交所,博士后董事长丁文锋隐去了一段履历
Sou Hu Cai Jing· 2025-07-07 13:51
瑞财经 严明会6月30日,深圳市维琪科技股份有限公司(以下简称:维琪科技)北交所IPO获受理,保 荐机构国信证券,保荐代表人楼瑜、郑桂斌,会计师事务所为致同会计师事务所。 截至招股说明书签署日,公司拥有16个经国家药监局批准备案的化妆品新原料, 其中包括7个创新新原 料,公司新原料备案获批数量位居第一,创新新原料备案获批数量位居第一。维琪科技已进入丸美、宝 洁等国内外知名品牌供应链体系。 丁文锋、赖燕敏夫妻为维琪科技共同实际控制人,二人合计控制公司 62.1%的股权。 董事长兼总经理丁文锋直接持有57.28%的股份,并担任公司员工持股平台维聚康的执行事务合伙人, 通过维聚康间接控制公司1.27%的股份,丁文锋直接和间接合计控制公司 58.55%的股份,为公司控股股 东。 丁文锋,48岁,博士研究生学历,2000年9月至2001年1月就职于深圳市万乐药业有限公司,担任研发人 员;2001年2月至2014年3月就职于康哲医药研究(深圳)有限公司,从事新药研发;2014 年至今就职于维 琪科技,现任公司董事长兼总经理。 | 品牌商 | 产品 | 使用公司新原料 | | --- | --- | --- | | 丸美 ...